TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03675074

Neujia Anastomosis for Treatment of Obesity and Type II Diabetes

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Deployment site not obtained in 5 patients with endoscopic screening and intent-to-treat. No devices implanted and no AEs through 30days.”

The sponsor’s own words in the registry.

Life of this trial

201820192020Registered2018-09-11Planned start2018-09-12 (planned)Withdrawn (as of)2019-02-04

Vital statistics

Status
Withdrawn
Phase
Na
Sponsor
Neurotronic, Inc.
Sponsor type
Industry
Conditions
Type2 Diabetes Mellitus; Obesity
Interventions
Neujia
Participants
0

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.